Similar articles

• [Mechanisms of action and clinical importance of C3-nephritic-factor (author's transl)].

  Lanzer G, Pogglitsch H, Tilz GP. Lanzer G, et al. Acta Med Austriaca. 1981;8(1):7-13. Acta Med Austriaca. 1981. PMID: 6908995 German.
• [Effects of C3 nephritic factor on the complement system--with special reference to stabilizing effect on C3 convertase (C3bBb) activity (author's transl)].

  Nakanishi I. Nakanishi I. Nihon Jinzo Gakkai Shi. 1981 Jun;23(6):719-32. Nihon Jinzo Gakkai Shi. 1981. PMID: 6914399 Japanese. No abstract available.
• Effect of decay-accelerating factor on the assembly of the classical and alternative pathway C3 convertases in the presence of C4 or C3 nephritic factor.

  Ito S, Tamura N, Fujita T. Ito S, et al. Immunology. 1989 Dec;68(4):449-52. Immunology. 1989. PMID: 2481642 Free PMC article.
• [Progress in the immunochemical studies of complement--including the establishment of nomenclature of complement proteins].

  Inai S. Inai S. Nihon Rinsho. 1979 May 10;37(5):923-9. Nihon Rinsho. 1979. PMID: 381722 Review. Japanese. No abstract available.
• The natural history of membranoproliferative glomerulonephritis: its relation to the hypocomplementemia.

  West CD, Ruley EJ, Spitzer RE, Davis NC. West CD, et al. Perspect Nephrol Hypertens. 1973;1 Pt 1:531-40. Perspect Nephrol Hypertens. 1973. PMID: 4620926 Review. No abstract available.